ArticleRisk analysis : an official publication of the Society for Risk Analysis2026
Toward AI-Assisted Methodological Evaluations of Health Risk Analyses Using Diverse Types of Evidence.
Article in Risk analysis : an official publication of the Society for Risk Analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
How should the credibility of claims about the human health effects of exposures be evaluated when their support consists of multiple individually inconclusive lines of evidence? Health risk analysis typically draws on heterogeneous evidence streams-including observational epidemiology, systematic reviews and meta-analyses, mechanistic and toxicological evidence, and policy-facing syntheses-to support causal conclusions and risk management recommendations. However, important distinctions among observed associations, causal interpretations, mechanistic plausibility, and claims about intervention or policy effectiveness are often blurred in scientific reviews and evidence syntheses, making evaluations difficult to reproduce, audit, or systematically critique. This article introduces ASP1 (Automated Scientific Paper reviewer 1), available online at https://moirai.shinyapps.io/asp1_pdf_runner/, an AI-assisted framework for systematic, transparent evaluation of heterogeneous scientific evidence and of the conclusions drawn from it. ASP1 combines modular review components, structured claim extraction, explicit linkage between evaluative judgments and supporting text, and cross-module synthesis to expose and systematically examine the evidentiary and inferential chain connecting a document's evidence to its conclusions. We illustrate it using a mini-corpus of recent publications concerning ultra-processed foods (UPFs) and health spanning prospective cohort studies, case-control studies, umbrella reviews, mechanistic syntheses, and policy-facing evidence reviews. Results can be browsed at https://moirai.shinyapps.io/asp1_bundle_browser/. Across these diverse study designs, ASP1 consistently distinguished evidence of association from stronger causal and interventional claims and identified important limitations involving residual confounding, exposure misclassification, mechanistic uncertainty, category heterogeneity, and overextension of policy conclusions beyond direct evidentiary support. Comparison with independent expert human commentary on a recent Lancet review showed substantial overlap in major inferential concerns identified by ASP1 and by skilled human reviewers, while also revealing complementary strengths. ASP1 was generally stronger in explicit inferential decomposition, claim-specific support classification, consistency, and auditability; human experts contributed richer contextual understanding, sharper methodological intuition, and more vivid and concrete examples of evidentiary limitations. These results suggest that current AI systems guided by structured evaluative frameworks can support more transparent, reproducible, and disciplined review of heterogeneous scientific evidence at realistic scales. The greatest promise of such systems may lie less in automating scientific judgment than in helping make scientific reasoning more explicit, inspectable, auditable, and open to challenge.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.